Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era-Reference-Cited by-同舟云学术

Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era

Published:2014-01-29 Issue:1 Volume:117 Page:153-160
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

McNamara Mairéad G.,Lwin Zarnie,Jiang Haiyan,Chung Caroline,Millar Barbara-Ann,Sahgal Arjun,Laperriere Normand,Mason Warren P.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-014-1368-7.pdf

Reference15 articles.

1. Central Brain Tumor Registry of the United States (CBTRUS) (2009) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004–2005. www.cbtrus.org/reports/reports.html . Accessed 10 Dec 2013

2. Gurney JG, Kadan-Lottick N (2001) Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 13:160–166

3. Walker MD, Alexander E Jr, Hunt WE et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:333–343

4. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

5. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC–NCIC trial. Lancet Oncol 10:459–466

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioblastoma stem cell long non-coding RNAs: therapeutic perspectives and opportunities;Frontiers in Genetics;2024-07-02

2. KHDRBS3 facilitates self-renewal and temozolomide resistance of glioblastoma cell lines;2024-06-17

3. miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease;Current Medicinal Chemistry;2024-06

4. T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression;Cancers;2024-01-31

5. Conditional survival probability of distant-metastatic hepatocellular carcinoma: A population-based study;World Journal of Gastrointestinal Oncology;2023-11-15